stromelysin inhibitors (Hoffmann-La Roche)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namestromelysin inhibitors (Hoffmann-La Roche)
Drug Alias NameRo-25-2812Ro-26-5726Ro-25-7812Ro-26-4325Ro-26-6307 +[6] 
ClassificationSmall molecules
Mechanisms of ActionMatrix metalloproteinase 3 inhibitors
TargetsMatrix metalloproteinase 3
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A